Sorsby pseudoinflammatory fundus dystrophy is a rare, inherited eye disorder that affects the retina. It is characterized by the presence of yellowish-white deposits in the macula, which can lead to vision loss. Symptoms typically begin in adulthood and include blurred vision, difficulty reading, and difficulty seeing in dim light. Treatment is typically focused on managing symptoms and preventing further vision loss.

The primary symptom of Sorsby pseudoinflammatory fundus dystrophy is progressive vision loss. Other symptoms may include:

- Blurred vision

- Difficulty seeing in dim light

- Difficulty reading

- Difficulty recognizing faces

- Difficulty seeing colors

- Loss of peripheral vision

- Floaters in the vision

- Photophobia (sensitivity to light)

- Eye Pain or discomfort

- Headaches

- Eye fatigue

Sorsby pseudoinflammatory fundus dystrophy is caused by a mutation in the TIMP3 gene, which is responsible for producing a protein that helps regulate the breakdown of collagen in the eye. This mutation leads to an accumulation of collagen in the eye, which can cause vision problems.

The primary treatment for Sorsby pseudoinflammatory fundus dystrophy is to slow the progression of the disease. This can be done through lifestyle changes such as avoiding smoking, eating a healthy diet, and exercising regularly. Additionally, medications such as antioxidants, anti-inflammatory drugs, and vitamins may be prescribed to help reduce inflammation and slow the progression of the disease. In some cases, laser photocoagulation may be used to reduce the risk of vision loss. Finally, regular eye exams are important to monitor the progression of the disease and to detect any changes in vision.

1. Age: Sorsby pseudoinflammatory fundus dystrophy typically affects individuals between the ages of 40 and 60.

2. Gender: Women are more likely to be affected than men.

3. Family history: Individuals with a family history of Sorsby pseudoinflammatory fundus dystrophy are at an increased risk of developing the condition.

4. Smoking: Smoking has been linked to an increased risk of developing Sorsby pseudoinflammatory fundus dystrophy.

At this time, there is no known cure for Sorsby pseudoinflammatory fundus dystrophy. However, there are medications that can be used to manage the symptoms of the condition. These medications include topical corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and antiglaucoma medications. Additionally, laser photocoagulation may be used to reduce the risk of vision loss.